Pepdox
Studies
Peptides
Calculator
Author Reply to The semaglutide paradox in non-overweight diabetes: a benefit without explanation. | Pepdox
Home
/
Search
/
PMID 40826494
Author Reply to The semaglutide paradox in non-overweight diabetes: a benefit without explanation.
European heart journal. Quality of care & clinical outcomes
2025
PMID: 40826494
View on PubMed
DOI: 10.1093/ehjqcco/qcaf090
Semaglutide
Authors
Kishimori, Takefumi; Kato, Takao